Evaluating quality of life after bladder cancer treatment
Quality of Life After Treatment for Bladder Cancer: The Bladder Cancer Survivorship Study
Mayo Clinic · NCT06350734
This study looks at how treatment for localized bladder cancer affects patients' quality of life over time and what factors might influence their experiences.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 704 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Mayo Clinic (other) |
| Drugs / interventions | radiation |
| Locations | 3 sites (Scottsdale, Arizona and 2 other locations) |
| Trial ID | NCT06350734 on ClinicalTrials.gov |
What this trial studies
This observational study assesses the impact of treatment for localized bladder cancer on patients' quality of life. It aims to compare general and disease-specific quality of life outcomes at various intervals post-treatment using validated tools like PROMIS-29 and the Bladder Cancer Index. Additionally, the study seeks to identify patient characteristics that may influence these quality of life outcomes. Participants will complete surveys and have their medical records reviewed as part of the study.
Who should consider this trial
Good fit: Ideal candidates are individuals with pathologically confirmed, clinically localized bladder cancer who can complete surveys in English.
Not a fit: Patients who do not meet the inclusion criteria or those with advanced bladder cancer may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into how bladder cancer treatments affect patients' quality of life, guiding future care and support.
How similar studies have performed: Other studies have shown success in evaluating quality of life in cancer patients, making this approach both relevant and valuable.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Have pathologically confirmed, clinically localized, bladder cancer * Be willing to complete a survey in English before starting definitive treatment (surgery or radiation); * Able to give consent. Exclusion Criteria: * Does not meet inclusion criteria
Where this trial is running
Scottsdale, Arizona and 2 other locations
- Mayo Clinic in Arizona — Scottsdale, Arizona, United States (RECRUITING)
- Mayo Clinic in Florida — Jacksonville, Florida, United States (RECRUITING)
- Mayo Clinic in Rochester — Rochester, Minnesota, United States (RECRUITING)
Study contacts
- Principal investigator: Mark D. Tyson, M.D., M.P.H. — Mayo Clinic
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Stage 0a Bladder Cancer AJCC v8, Stage 0is Bladder Cancer AJCC v8, Stage I Bladder Cancer AJCC v8, Stage II Bladder Cancer AJCC v8, Stage IIIA Bladder Cancer AJCC v8